首页> 外文期刊>Molecular BioSystems >Exploring resistance mechanisms of HCV NS3/4A protease mutations to MK5172: insight from molecular dynamics simulations and free energy calculations
【24h】

Exploring resistance mechanisms of HCV NS3/4A protease mutations to MK5172: insight from molecular dynamics simulations and free energy calculations

机译:探索HCV NS3 / 4A蛋白酶突变对MK5172的抗性机制:分子动力学模拟和自由能计算的启示

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Mutations at a number of key positions (Ala156, Asp168 and Arg155) of the HCV NS3/4A protease can induce medium to high resistance to MK5172. The emergence of the resistant mutations seriously compromises the antiviral therapy efficacy to hepatitis C. In this study, molecular dynamics (MD) simulations, free energy calculations and free energy decomposition were used to explore the interaction profiles of MK5172 with the wild-type (WT) and four mutated (R155K, D168A, D168V and A156T) HCV NS3/4A proteases. The binding free energies predicted by Molecular Mechanics/Generalized Born Solvent Area (MM/GBSA) are consistent with the trend of the experimental drug resistance data. The free energy decomposition analysis shows that the resistant mutants may change the protein-MK5172 interaction profiles, resulting in the unbalanced energetic distribution amongst the catalytic triad, the strand 135-139 and the strand 154-160. Moreover, umbrella sampling (US) simulations were employed to elucidate the unbinding processes of MK5172 from the active pockets of the WT HCV NS3/4A protease and the four mutants. The US simulations demonstrate that the dissociation pathways of MK5172 escaping from the binding pockets of the WT and mutants are quite different, and it is quite possible that MK5172 will be harder to get access to the correct binding sites of the mutated proteases, thereafter leading to drug resistance.
机译:HCV NS3 / 4A蛋白酶在多个关键位置(Ala156,Asp168和Arg155)的突变可诱导对MK5172的中等至高抗性。抗性突变的出现严重损害了对丙型肝炎的抗病毒治疗功效。在这项研究中,使用分子动力学(MD)模拟,自由能计算和自由能分解来探索MK5172与野生型(WT )和四种突变的(R155K,D168A,D168V和A156T)HCV NS3 / 4A蛋白酶。由分子力学/广义生化溶剂面积(MM / GBSA)预测的结合自由能与实验耐药性数据的趋势一致。自由能分解分析表明,抗性突变体可能会改变蛋白质-MK5172相互作用,从而导致催化三联体,链135-139和链154-160之间的能量分布不平衡。此外,采用伞式采样(美国)模拟来阐明MK5172从WT HCV NS3 / 4A蛋白酶的活性口袋和四个突变体的解离过程。美国模拟表明,从野生型和突变体的结合口袋逃逸的MK5172的解离途径是完全不同的,并且很可能MK5172将更难获得突变蛋白酶的正确结合位点,随后导致耐药性。

著录项

  • 来源
    《Molecular BioSystems》 |2015年第9期|2568-2578|共11页
  • 作者单位

    College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 310058, China,Institute of Functional Nano & Soft Materials (FUNSOM), Soochow University, Suzhou, Jiangsu 215123, China;

    College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 310058, China;

    College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 310058, China;

    Institute of Functional Nano & Soft Materials (FUNSOM), Soochow University, Suzhou, Jiangsu 215123, China;

    College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 310058, China;

    College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 310058, China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号